Iovera is a cryoanalgesia technology that allows healthcare providers to block pain for immediate and long-term relief by delivering precise cold therapy to a targeted nerve.
It has shown long-term effectiveness in the treatment of knee pain, stopping nerves from sending pain signals for up to 90 days.
It is administered with a nonsurgical handheld device and does not cause any damage to the surrounding knee tissue.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
